clofibrate has been researched along with nicardipine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Itoga, H; Okawa, S; Suga, T; Tamura, H; Watanabe, T | 1 |
| Itoga, H; Suga, T; Tamura, H; Watanabe, T | 1 |
| Suga, T; Watanabe, T | 1 |
| Maeno, H; Nagano, K; Ohata, I; Sakamoto, N | 1 |
1 review(s) available for clofibrate and nicardipine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for clofibrate and nicardipine
| Article | Year |
|---|---|
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Co-suppression by nicardipine, a calcium antagonist, of induction of microsomal lauric acid hydroxylation with peroxisome proliferation in clofibrate-treated rat liver.
Topics: Animals; Clofibrate; Hydroxylation; In Vitro Techniques; Lauric Acids; Liver; Male; Microbodies; Microsomes, Liver; Nicardipine; Rats; Rats, Inbred Strains | 1991 |
Characteristics of the suppressive effect of nicardipine on peroxisome induction in rat liver.
Topics: 3-Hydroxyacyl CoA Dehydrogenases; Animals; Clofibrate; Dietary Fats; Electrophoresis, Polyacrylamide Gel; Enoyl-CoA Hydratase; Enzyme Induction; Hydro-Lyases; Liver; Male; Microbodies; Mitochondria, Liver; Nicardipine; Rats; Rats, Inbred Strains | 1990 |
Suppression of clofibrate-induced peroxisome proliferation in rat liver by nicardipine, a calcium antagonist.
Topics: 3-Hydroxyacyl CoA Dehydrogenases; Acyl-CoA Dehydrogenase; Animals; Carnitine O-Acetyltransferase; Carnitine O-Palmitoyltransferase; Catalase; Clofibrate; D-Amino-Acid Oxidase; Diltiazem; Enoyl-CoA Hydratase; Enzyme Induction; Enzyme Inhibitors; Fatty Acid Desaturases; Liver; Male; Microbodies; Nicardipine; Nifedipine; Rats; Rats, Inbred Strains; Triglycerides | 1988 |
Low density lipoprotein-lowering and high density lipoprotein-elevating effects of nicardipine in rats.
Topics: Acetates; Animals; Cholesterol; Clofibrate; Hypercholesterolemia; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Male; Nicardipine; Nifedipine; Rats; Rats, Inbred Strains; Sterols | 1984 |